Valuation: cbdMD, Inc.

Capitalization 8.61M 7.38M 6.88M 6.4M 11.81M 741M 13.19M 83.11M 31.37M 347M 32.28M 31.61M 1.28B P/E ratio 2025 *
-0.24x
P/E ratio 2026 * -1.1x
Enterprise value 8.61M 7.38M 6.88M 6.4M 11.81M 741M 13.19M 83.11M 31.37M 347M 32.28M 31.61M 1.28B EV / Sales 2025 *
0.42x
EV / Sales 2026 * 0.38x
Free-Float
59.86%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+4.32%
1 week-0.09%
Current month+8.32%
1 month+15.27%
3 months-47.50%
6 months-75.97%
Current year-67.80%
More quotes
1 week 0.89
Extreme 0.89
1.01
1 month 0.82
Extreme 0.82
1.01
Current year 0.76
Extreme 0.76
6.54
1 year 0.76
Extreme 0.76
6.54
3 years 0.76
Extreme 0.76
320.4
5 years 0.76
Extreme 0.76
2,458.8
10 years 0.76
Extreme 0.76
2,606.4
More quotes
Manager TitleAgeSince
Chief Executive Officer 45 2023-02-28
Chief Tech/Sci/R&D Officer - 2018-12-31
Chief Tech/Sci/R&D Officer 44 -
Director TitleAgeSince
Director/Board Member 40 2017-02-28
Director/Board Member 65 2019-04-18
Chairman 59 2022-06-02
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+4.32%-0.09%-80.52%-99.34% 8.61M
+1.34%-2.69%-9.09%+139.83% 693B
+0.44%+4.33%+5.33%-6.04% 394B
-1.12%-1.66%+10.59%+26.54% 334B
-2.22%-5.55%-53.26%-1.90% 287B
+0.58%+0.66%-7.15%-21.43% 259B
-1.12%-4.09%-2.94%+12.40% 223B
-0.17%-1.49%-15.11%-7.23% 215B
-1.91%-4.08%-35.65%-13.41% 201B
-1.17%-0.17%-10.94%+20.88% 158B
Average -0.03%-1.62%-19.87%+5.03% 276.49B
Weighted average by Cap. -0.41%-1.66%-11.07%+35.84%
See all sector performances

Financials

2025 *2026 *
Net sales 20.56M 17.64M 16.44M 15.3M 28.22M 1.77B 31.51M 199M 74.97M 830M 77.14M 75.54M 3.05B 22.62M 19.41M 18.08M 16.83M 31.04M 1.95B 34.66M 218M 82.47M 913M 84.86M 83.1M 3.36B
Net income -2.98M -2.55M -2.38M -2.21M -4.08M -256M -4.56M -28.73M -10.85M -120M -11.16M -10.93M -442M -1.02M -873K -814K -757K -1.4M -87.67M -1.56M -9.83M -3.71M -41.11M -3.82M -3.74M -151M
Net Debt - -
More financial data * Estimated data
Logo cbdMD, Inc.
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Employees
42
More about the company
Date Price Change Volume
25-07-18 0.9660 $ +4.32% 30,796
25-07-17 0.9260 $ +0.58% 12,341
25-07-16 0.9207 $ -4.74% 19,414
25-07-15 0.9665 $ +0.68% 46,028
25-07-14 0.9600 $ -0.71% 197,378

Delayed Quote Nyse, July 18, 2025 at 04:00 pm EDT

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9660USD
Average target price
3.000USD
Spread / Average Target
+210.56%
Consensus

Quarterly revenue - Rate of surprise